Latest News

Amended Rules

posted Dec 20, 2018, 2:54 PM by Carmen Orla   [ updated Feb 5, 2019, 8:27 AM ]

Final Amended rules can now be found here.

A summary of the Amended Rules can be found here

Attention Compounders

posted Aug 14, 2018, 1:49 PM by Carmen Orla   [ updated Aug 14, 2018, 2:55 PM ]

USP <797> & <825> Are Open for Public Comment

     The new revised USP <797> chapter on sterile preparations & the USP <825> chapter on radiopharmaceuticals are now open for public comment.  USP General Chapter <797> provides standards for compounding quality sterile preparations.  You can access the new version of <797> here

This is the second round of public comments for USP <797>. It was opened for public comment July 27, 2018.  The public comment period will run through November 30, 2019.  

You can also register for the open microphone session scheduled for September 5, 2018, through the link above. During the Open Microphone session, USP will highlight proposed revised standards and answer questions about the approach of the revisions.

 These new revisions eliminate the section Radiopharmaceuticals as Compounded Sterile Preparations (CSPs) and replace it with a reference to General Chapter 825 Radiopharmaceuticals ‒ Preparation, Compounding, Dispensing, and Repackaging.  USP <825> is available here and is also open for comment through November 30, 2018.

Practitioner Required WORx Registration

posted Apr 17, 2018, 10:58 AM by Carmen Orla   [ updated Jul 6, 2018, 3:14 PM ]

New Practitioner Worx PDMP Required Registration


·         New legislative language (SF0083) requires all practitioners to register for WORx at  This is something that can be done today and practitioners can review controlled substances their patients may have received from other practitioners prior to their treatment.

 ·         Reporting by dispensing practitioners (i.e. veterinarians, dentists, physicians, nurse practitioners, etc…) has not begun.  Administrative rules and regulations have to be developed in collaboration with the other practitioner licensing boards and will include the specific reporting requirements.

 ·         An exemption for administering medications during in-office procedures and treatments may be included in the newly developed administrative rules.

 ·         If supplies of gabapentin, cyclobenzaprine, naloxone, or controlled substances (i.e. tramadol, oxycodone, etc...) are provided by practitioners for home use, they will likely need to be reported under the new rules once they are developed.

 ·         When the new rules have been developed Controlled Substance Registrants will be notified and our website will be updated to reflect the new requirements.  Developing rules will take several months.  Practitioner Controlled Substance Registrants who dispense do not need to report dispensed prescriptions at this time. 

Shingles vaccine

posted Feb 20, 2018, 11:47 AM by Carmen Orla   [ updated Feb 20, 2018, 12:15 PM ]

You can now administer the Shingrix vaccine, as prescribing and administering of a zoster vaccine is within the pharmacist’s scope of practice. According to current Wyoming law, there is no specification as to which zoster vaccination can be prescribed and administered. This is under the assumption that the immunizer (pharmacist or intern) is current on their immunization licensing, has reviewed the package insert, and that all vaccine-specific patient criteria put forth by the CDC are met.

Wyoming WPA Chapter 16, Section 5, Immunization Regulation in Adults as follows:


“Section 5. Adults.

(a) Vaccines which a pharmacist may prescribe and administer to healthy adults or

may be administered by a prescription of a physician for high risk adults shall be restricted to:


(i) Human papillomavirus (HPV);

(ii) Hepatitis A;

(iii) Hepatitis B;

(iv) Influenza;

(v) Measles, mumps, rubella (MMR);

(vi) Meningococcal;

(vii) Pneumococcal;

(viii) Tetanus, diphtheria, pertussis (Td, Tdap);

(ix) Varicella; and

(x) Zoster.”


Recent Pharmacy Robberies

posted Jan 26, 2018, 12:06 PM by Carmen Orla   [ updated Jan 26, 2018, 12:25 PM ]

Recent pharmacy robberies have been reported in Torrington, Douglas, Thayne and Sundance.  It appears that independently owned pharmacies are being targeted.  You may wish to increase your security and provide staff education on prevention tips, what to do during a robbery, and what needs to be done after. 

Prevention may include:

·       Installing alarm and video surveillance systems

·       Posting signs that announce surveillance equipment is utilized

·       Installation of panic buttons, window bars, safety glass and reinforced doors

·       Storing controlled substances in a safe

·       Installing bright lights and video surveillance to monitor the outside of your pharmacy

·       You may wish see if the local police can conduct a security assessment for your pharmacy

 What you do during a robbery may include:

·       Cooperate.  Do not resist and potentially aggravate the robber

·       Try to remain calm and avoid sudden or fast movements

·       Try to keep yourself and others safe.  Do not try to apprehend the criminal yourself

 What to do after a robbery may include:

·       Get treatment for anyone who has been injured

·       Call police

·       Lock doors to prevent possible re-entry, until police arrive

·        Write down what you remember as soon as you can.  The quicker the better.

·       Once you determine what has been stolen, report controlled substance loss on a DEA 106 form and report it to the DEA along with a copy to the Wyoming State Board of Pharmacy


·       Pharmacy Security Checklist available at:

·       DEA Pharmacy Robbery & Burglary. Tips to Protect Your Customers, Your Business, and Yourself available at:

·       DEA Form 106 – Theft or Loss of Controlled Substances online form and instructions available at:



posted Oct 12, 2017, 12:35 PM by Art Bailey   [ updated Nov 17, 2017, 12:55 PM by Carmen Orla ]

The Emergency Administration of Opiate Antagonist Act was passed in 2017. It allows a pharmacist to prescribe and dispense an opiate antagonist (naloxone) to a person at risk of experiencing an opiate related drug overdose, to a person in a position to assist a person at risk of an opiate overdose, or to a person who, in the course of their official duties or business, may encounter a person experiencing an opiate related drug overdose. An informational brochure may be downloaded by clicking here. A sample prescription may be downloaded by clicking here. A summary of the rules for a pharmacist who prescribes naloxone may be downloaded by clicking here. Refer to the Wyoming Pharmacy Act Rules Chapter 18 under the “laws” tab.

                                                                                                        Informational brochure

                                                                                                        Sample Naloxone prescription

                                                                                                        Summary of the rules

New Laws

posted Oct 12, 2017, 12:32 PM by Art Bailey   [ updated Jan 17, 2018, 12:36 PM by Carmen Orla ]

Recently revised rules and regulations signed by Governor Mead in May 2017 include Chapters 4, 6, 7, and 8 under the WY Controlled Substances Act and Chapters 1, 15, 16, and 17 under the WY Pharmacy Act. A summary of the changes can be downloaded by clicking here

New rules signed by Governor Mead in October 2017 under the WY Pharmacy Act Chapter 2 General Practice of Pharmacy, Chapter 8 Wholesale Distributors, Chapter 14 Telepharmacy, and Chapter 18 Prescribing by Pharmacists. A summary of the changes can be downloaded by clicking here.

The new versions are under the Laws tab.

1-8 of 8